Buradasınız

DEVELOPMENT AND VALIDATION OF DUAL WAVELENGTH UV SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF TADALAFIL AND DAPOXETINE HYDROCHLORIDE IN THEIR COMBINED TABLET DOSAGE FORM

Journal Name:

Publication Year:

Abstract (2. Language): 
The present manuscript describes simple, sensitive, rapid, accurate, precise and economical dual wavelength spectrophotometric method for the simultaneous determination of Tadalafil and Dapoxetine Hydrochloride in combined tablet dosage form. The principle for dual wavelength method is "the absorbance difference between two points on the mixture spectra is directly proportional to the concentration of the component of interest". The method was based on determination of Dapoxetine Hydrochloride at the absorbance difference between 280.0 nm and 295.4 nm and Tadalafil at the absorbance difference between 255.0 nm and 298.2 nm. The linearity was obtained in the concentration range of 4-24 ug/ml and 10-60 ug/ml for Tadalafil and Dapoxetine Hydrochloride respectively. The method was successfully applied to pharmaceutical dosage form because no interference from the tablet excipients was found. The suitability of these methods for the quantitative determination of Tadalafil and Dapoxetine Hydrochloride was proved by validation and recovery study. The proposed methods were found to be simple and sensitive for the routine quality control application ofTadalafil and Dapoxetine Hydrochloride in pharmaceutical tablet dosage form.

REFERENCES

References: 

1. Kiran
Kuma
r D, Nataraj KS, Kesinath R and Suresh Kumar S: Method Development and Validation for Analysis of Dapoxetine in Bulk and Pharmaceutical Dosage Form by RP-HPLC"; International Journal of Chem Tech Research; 2010: 205-211.
2.
SVV
. Dhanu Radha. IJRRPAS. 2011 ; 1(3) : 172-178.
3.
Dru
g Bank: Tadalafil November 2011. www.drugbank.ca/drugs/DB00820
4. Samuel L. Washington and Alan W Shindel. Drug Design, Development and Therapy. 2010; l (4):160-171.
5.
Dru
g Bank: "Dapoxetine Hydrochloride" November 2011 www.drugbank.ca/drugs/DB00539
6.
Mohamma
d Y, Gowrie Sankar, Pragati Kumar and Shahul H. E-journal of chemistry http://www.e-journals.net 2010; 7(3): 833-836.
7. Adlin
Jin
o Nesalin, Jose Gnana Babu, Vijaya Kumar and Tamizh mani. E-journal of chemistry http://www.e-journals.net 2009; 6(3): 611-614.
8.
B
. Prasanna Reddy, K. Amarnadh Reddy and M. S. Reddy: Validation and stability indicating RP-HPLC method for the determination of tadalafil API in pharmaceutical formulations. Research in Pharmaceutical Biotechnology. 2010; 2(1):
1-6.
9.
Sutha
r AS, Magdum CS, Patil SS and Naikawadi NS: Rp-hplc Estimation of Tadalafil in Tablet Dosage Form. Int. J.
em. Sci. 2008; 6(2): 1223-1227.
10.
Asho
k K Shakya, Ahmed NA, Tewfik AA, Munther Melhim. Journal of Chromatography B Analytical Technologies In The Biomedical And Life Sciences", 2000; 852(1-2): 403-8.
11. Ramakrishna NVS, Vishwottam KN, Koteshwara M. Journal of Chromatography B, 2004; 809(2): 243¬49.
12. Kannappan N, Yada D, Shashikanth and Mannavalan R: Method development
and validation of stability indicating methods for assay of Tadalafil and sildenafil citrate by HPLC. International Journal of Chem Tech Research. 2010; 2(1): 329-333.
13. Mehta P, Sahoo U and Seth AK: Development and Validation of a RP-HPLC Method for the Determination of Dapoxetine Hydrochloride in Pharmaceutical Formulation Using an Experimental. International Journal of Pharma World Research, 2011; 6(2): 15.
14. Drug Bank: "Dapoxetine Hydrochloride" November 2011 www.drugbank.ca/drugs/DB00539 .
15. Martin Dale, Pharmaceutical press, 2005; 34th edition, 1751.
Available Online

Thank you for copying data from http://www.arastirmax.com